Literature DB >> 10954677

Treatment of lipodermatosclerosis with oxandrolone in a patient with stanozolol-induced hepatotoxicity.

S Segal, J Cooper, J Bolognia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10954677     DOI： 10.1067/mjd.2000.106517

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  3 in total

Review 1.  The anabolic androgenic steroid oxandrolone in the treatment of wasting and catabolic disorders: review of efficacy and safety.

Authors:  Rhonda Orr; Maria Fiatarone Singh
Journal:  Drugs       Date:  2004       Impact factor: 9.546

2.  Performance-Enhancing Drugs Abuse Caused Cardiomyopathy and Acute Hepatic Injury in a Young Bodybuilder.

Authors:  Cheng Li; Binay Kumar Adhikari; Lu Gao; Shuai Zhang; Quan Liu; Yonggang Wang; Jian Sun
Journal:  Am J Mens Health       Date:  2018-06-21

3.  Oxandrolone for treatment of lipodermatosclerosis: case report.

Authors:  Leonardo Amédée Péret; Heloisa Malaquias Vidal; Gabriela Alves Cardoso Gomes; Gabriel Victor Borba Oliveira; Lainara Magalhães Aguiar
Journal:  J Vasc Bras       Date:  2019-10-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.